DDInter631 DDInter442
Eltrombopag is used to treat low blood platelet counts in adults with chronic immune (idiopathic) thrombocytopenia (ITP), when certain other medicines, or surgery to remove the spleen, have not worked well enough. ITP is a condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood. Eltrombopag has also been recently approved (late 2012) for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Copper gluconate is a copper salt of D-gluconic acid that displays a light blue to bluish-green color. It is prepared by the reaction of gluconic acid solutions with cupric oxide or basic cupric carbonate. According to the good manufacturing or feeding practice by the FDA, copper gluconate is used as a nutrient or dietary supplement and is generally recognized as safe for use at a level not exceeding 0.005 percent.
Eltrombopag {u} (Compound) binds {v} (Gene) CYP2C8
Eltrombopag {u} (Compound) is included by {v} (Pharmacologic Class) Thrombopoietin Receptor Agonists
Eltrombopag {u} may cause a minor interaction that can limit clinical effects when taken with {v} Boceprevir
Eltrombopag {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Idelalisib
Eltrombopag {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Simvastatin
Eltrombopag {u} may lead to a major life threatening interaction when taken with {v} Berotralstat
Eltrombopag {u} may lead to a major life threatening interaction when taken with {v} Peginterferon alfa-2b
Eltrombopag (Compound) binds CYP2C8 (Gene)
Eltrombopag (Compound) is included by Thrombopoietin Receptor Agonists (Pharmacologic Class)
Eltrombopag may cause a minor interaction that can limit clinical effects when taken with Boceprevir
Eltrombopag may cause a moderate interaction that could exacerbate diseases when taken with Idelalisib
Eltrombopag may cause a moderate interaction that could exacerbate diseases when taken with Simvastatin
Eltrombopag may lead to a major life threatening interaction when taken with Berotralstat
Eltrombopag may lead to a major life threatening interaction when taken with Peginterferon alfa-2b